Novo Nordisk A/S ADR | Key People and Executives
Marcus Schindler
Director, SVP-External Innovation & Strategy
Mette Bøjer Jensen
Director
Anne Marie Handrup Kverneland
Director
Jeppe Fonager Christiansen
Vice Chairman
Søren Thuesen Pedersen
Director
Brian F. Daniels
Independent Director
Elizabeth Anne Hewitt
Independent Director
Sylvie Louise Grégoire
Independent Director
Lars Fruergaard Jørgensen
President & Chief Executive Officer
Maziar Mike Doustdar
Executive Vice President-International Operations
Karsten Munk Knudsen
Chief Financial Officer
Alan C. Moses
Senior Vice President & Chief Medical Officer
Mads Krogsgaard Thomsen
Chief Science Officer & Executive Vice President
Robin Evers
SVP-Medical Affairs, Regulatory & Safety
Marcus Schindler
Director, SVP-External Innovation & Strategy
Stephen Gough
Global Chief Medical Officer
Doug Langa
EVP & Head-North America Operations
Lars Green
Executive VP, Head-Business Services & Compliance
Henrik Ehlers Wulff
Executive Vice President-Product Supply
Camilla Sylvest
EVP-Commercial Strategy & Corporate Affairs
Mette Bøjer Jensen
Director
Anne Marie Handrup Kverneland
Director
Jeppe Fonager Christiansen
Vice Chairman
Søren Thuesen Pedersen
Director
Peter Hugreffe Ankersen
Vice President & Head-Investor Relations
Mike Rulis
Senior Vice President-Corporate Affairs
Charlotte Zarp-Andersson
Lead-Media Relations
Katrine Sperling
Vice President-Media Relations
Anne Margrethe Hauge
Manager-Media Relations
Krisja Vermeylen
Senior Vice President-People & Organisation
Jesper Brandgaard
EVP-Biopharm & Legal Affairs
Brian F. Daniels
Independent Director
Elizabeth Anne Hewitt
Independent Director
Sylvie Louise Grégoire
Independent Director
| Address |
Novo Allé
Bagsværd CR 2880
Denmark
|
|
Employees
|
- |
| Website |
http://www.novonordisk.com |
| Updated |
07/08/2019 |
| Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following business segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. |
